Prothymosin Alpha: An Alarmin and More...

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Prothymosin alpha (proTα) is a polypeptide with known intracellular roles in cell proliferation and apoptosis.
• Its extracellular functions as a biologic response modifier, similar to alarmins, were not fully understood.
• This study aimed to elucidate the mechanisms behind proTα's immune-modulating activities.

Purpose of the Study:

• To investigate the role of proTα and its C-terminal decapeptide (proTα(100-109)) in immune responses.
• To identify the specific molecular pathways involved in proTα-mediated immune cell activation.
• To explore the potential of proTα and proTα(100-109) as biomarkers and therapeutic targets.

Main Methods:

• Measurement of proTα levels during cell proliferation.
• Analysis of proTα and proTα(100-109) interaction with immune cells, including neutrophils.
• Investigation of signaling pathways, specifically Toll-like receptor 4 (TLR-4) activation.
• Assessment of adjuvant effects on lymphocyte responses.
• Evaluation of proTα(100-109) as a biomarker in bacterial infections.

Main Results:

• ProTα levels increase during normal and abnormal cell proliferation.
• ProTα and proTα(100-109) stimulate innate immunity via TLR-4, leading to neutrophil activation and calcium influx.
• These molecules act as adjuvants, enhancing lymphocyte responses to antigens.
• ProTα(100-109) shows potential as a biomarker in severe bacterial infections.

Conclusions:

• Prothymosin alpha and its decapeptide fragment function as alarmins, mediating immune responses and acting as biomarkers.
• Their interaction with TLR-4 highlights a key mechanism in innate immunity.
• These findings suggest potential therapeutic and diagnostic applications for proTα in immune-related diseases such as cancer, inflammation, and sepsis.